TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RARE

Ultragenyx

Healthcare · Biotechnology

14.50$ +12.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Ultragenyx (RARE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 81.6% of the shares are freely tradable; institutional investors hold 104.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 104.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 81.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 18.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 99Mio.

Largest Shareholders

Institutions

Institutions RARE
Name Stake (%) Shares Change (%) Date
BlackRock Inc 7.40 7,299,598 +10.1 03/31/2026
Vanguard Portfolio Management, LLC 5.46 5,385,992 +0.0 03/31/2026
State Street Corp 5.09 5,021,441 +16.7 03/31/2026
AQR Capital Management LLC 4.64 4,578,024 +236.5 03/31/2026
Vanguard Capital Management, LLC 4.25 4,189,831 +0.0 03/31/2026
RTW INVESTMENTS, LLC 3.70 3,648,795 +21.6 03/31/2026
Two Sigma Investments LLC 3.67 3,621,200 +64.2 06/30/2026
Sands Capital Management, LLC 3.20 3,158,368 -1.7 06/30/2026
Sofinnova Ventures 3.19 3,145,888 +3,676.6 03/31/2026

Funds

Funds RARE
Name Stake (%) Shares Change (%) Date
State Street® SPDR® S&P® Biotech ETF 3.91 3,859,478 -1.1 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings RARE
Person Role Shares Value As of Type
Horn Howard Chief Financial Officer 96,295 1,396,278 $ Aug 3, 2026 direct
Parschauer Karah Herdman EVP and Chief Legal Officer 92,562 1,342,149 $ Aug 3, 2026 direct
Huizenga Theodore Alan SVP, Chief Accounting Officer 67,863 984,014 $ Sep 15, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 15, 2026 Huizenga Theodore Alan SVP, Chief Accounting Officer Sell 1,283 13.57 17,410
Sep 3, 2026 Huizenga Theodore Alan SVP, Chief Accounting Officer Sell 161 13.99 2,252
Aug 3, 2026 Parschauer Karah Herdman EVP and Chief Legal Officer Sell 1,900 24.92 47,348
Aug 3, 2026 Horn Howard Chief Financial Officer Sell 4,696 24.92 117,024

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?